Comments

Entourage Health

Q: What sector and industry does Entourage Health (ETRGF) operate in?

Entourage Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.

ETRGFOTCPK

Perks Buy Compare Brokers

15 minutes delayed

Entourage Health (ETRGF) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Entourage Health (OTC:ETRGF) Stock Quotes, Forecast and News Summary

Entourage Health Stock (OTC: ETRGF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 27.81K
Day Range	- - -
52 Wk Range	0.00 - 0.02
Market Cap	$3.28M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More

As the premier gathering of top entrepreneurs and investors is taking place this Monday in New Jersey, let's scroll through the latest leadership changes in the cannabis and psychedelics industries.Cybin Inc.announced recently that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, opted to join the company as senior vice president of clinical development. In addition, six cannabis companies announced changes to their respective boards of directors.

Jelena Martinovic

Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'

Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its first quarter financial results for the three months ended March 31, 2024. The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase. "Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO, said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."

Jelena Martinovic

Cannabis Co. Entourage Health Reports 126% YoY Increase In 2023 Gross Profit, Cuts Losses Significantly

Canadian cannabis producer and distributor Entourage Health Corp., announced on Tuesday its financial results for the fiscal year that ended Dec. 31, 2023. The Toronto-based company reported a total net revenue of CA$40.7 million ($29.8 million) in 2023, slightly down from CA$40.9 million in 2022. However, gross profit before fair value changes reached CA$2.4 million in the same period, representing a 126% year-over-year increase. "In 2023, Entourage made significant strides, advancing production and diversifying our market presence with innovative products," George Scorsis, CEO and executive chair, said. "Dime Bag's success is a prime example—quickly rising to become one of Ontario's fastest-growing pre-roll brands and maintaining its market leadership for two consecutive quarters. Driven by surging demand for our products and the effectiveness of our enhanced business model, we're achieving growth while improving cost efficiency, firmly establishing ourselves in a favorable financial position."

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Entourage Health Corp is a licence holder producing and distributing cannabis products for both the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entourage Health (ETRGF) stock?

You can purchase shares of Entourage Health (OTCPK:ETRGF) through any online brokerage.

View our list of the best stock brokerages

Who are Entourage Health (ETRGF) competitors?

There are no as such competitors for Entourage Health.

What is the target price for Entourage Health (ETRGF) stock?

There is no analysis for Entourage Health.

What is the forecast for Entourage Health (ETRGF) stock?

There is no analysis for Entourage Health to provide a consensus price target.

Current stock price for Entourage Health (ETRGF)?

The stock price for Entourage Health (OTCPK: ETRGF) is $0.01064 last updated July 24, 2024 at 12:32 PM EDT.

Does Entourage Health (ETRGF) pay a dividend?

There are no upcoming dividends for Entourage Health.

When is Entourage Health (OTCPK:ETRGF) reporting earnings?

Entourage Health does not have any upcoming earnings scheduled.

Is Entourage Health (ETRGF) going to split?

There is no upcoming split for Entourage Health.

What sector and industry does Entourage Health (ETRGF) operate in?

Entourage Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.